Lexicon Pharmaceuticals (NASDAQ:LXRX) Rating Lowered to Hold at Leerink Partnrs
Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) was downgraded by Leerink Partnrs from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports. Other analysts have also recently issued reports about the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Lexicon Pharmaceuticals […]
Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) was downgraded by Leerink Partnrs from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports. Other analysts have also recently issued reports about the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Lexicon Pharmaceuticals […]
